These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7282748)

  • 1. Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity.
    Gilbert HS; Ginsberg H; Fagerstrom R; Brown WV
    Am J Med; 1981 Oct; 71(4):595-602. PubMed ID: 7282748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypocholesterolemia in myeloproliferative diseases with myelofibrosis.
    Ginsberg H; Gilbert HS
    Prog Clin Biol Res; 1984; 154():345-57. PubMed ID: 6382303
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypocholesterolemia and other lipoprotein disorders in myelofibrosis].
    Kiss A; Telek B; Rák K
    Orv Hetil; 1994 Nov; 135(48):2643-6. PubMed ID: 7808738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein composition in agnogenic myeloid metaplasia.
    Léglise D; Abgrall JF; Desfontaine B; Dutel JL; Bardou LG; Brière J
    Biomed Pharmacother; 1985; 39(3):135-9. PubMed ID: 4063464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia.
    Ginsberg HN; Le NA; Gilbert HS
    Metabolism; 1986 Sep; 35(9):878-82. PubMed ID: 3747843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein (LDL) distribution shown by 99mtechnetium-LDL imaging in patients with myeloproliferative diseases.
    Vallabhajosula S; Gilbert HS; Goldsmith SJ; Paidi M; Hanna MM; Ginsberg HN
    Ann Intern Med; 1989 Feb; 110(3):208-13. PubMed ID: 2912361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibronectin in idiopathic myelofibrosis and related chronic myeloproliferative disorders.
    Hasselbalch H; Clemmensen I
    Scand J Clin Lab Invest; 1987 Sep; 47(5):429-33. PubMed ID: 3477850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in lipid and lipoprotein levels after weight training.
    Goldberg L; Elliot DL; Schutz RW; Kloster FE
    JAMA; 1984 Jul; 252(4):504-6. PubMed ID: 6737642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipids and lipoprotein disorders in cancer patients.
    Alexopoulos CG; Blatsios B; Avgerinos A
    Cancer; 1987 Dec; 60(12):3065-70. PubMed ID: 3677028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in plasma high density lipoprotein cholesterol with weight loss.
    Ruggiero M; Brunese M; Morelli S; Mangoni C; Stefano S
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):798-804. PubMed ID: 7272052
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased low-density lipoprotein levels after splenectomy: a role for the spleen in cholesterol metabolism in myeloproliferative disorders.
    Aviram M; Brook JG; Tatarsky I; Levy Y; Carter A
    Am J Med Sci; 1986 Jan; 291(1):25-8. PubMed ID: 3942157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
    Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
    J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects.
    Schaefer EJ; Levy RI; Ernst ND; Van Sant FD; Brewer HB
    Am J Clin Nutr; 1981 Sep; 34(9):1758-63. PubMed ID: 6945041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipid composition and LDL oxidation.
    Brizzi P; Tonolo G; Carusillo F; Malaguarnera M; Maioli M; Musumeci S
    Clin Chem Lab Med; 2003 Jan; 41(1):56-60. PubMed ID: 12636050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction.
    Brownell KD; Stunkard AJ
    Arch Intern Med; 1981 Aug; 141(9):1142-6. PubMed ID: 7259372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
    Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
    Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocholesterolemia in patients with polycythemia vera.
    Fujita H; Hamaki T; Handa N; Ohwada A; Tomiyama J; Nishimura S
    J Clin Exp Hematop; 2012; 52(2):85-9. PubMed ID: 23037623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.